4 September 2008 PharmaVOICE Leveraging Postapproval Research The postapproval landscape has changed for pharmaceutical manufacturers. Craig Eslinger of PPD addresses how data obtained in postmarketing safety surveillance can be used to a company’s advantage. 46 The Growing Influence of Global Payers In this payer dominated era, governments outside the United States have been increasing their demands for data about a product’s impact on the patient and the healthcare system. 54 DIA 2008 — Annual Conference The Drug Information Association’s 44th annual meeting was the largest in the association’s history. 58 ON THE COVER When Smaller is Better As the industry turns its attention toward specialty products in the hopes of filling drying pipelines, smaller pharma and biotech companies may find themselves in the driver’s seat. 8 FEATURES A New Era of Drug Safety New regulations in the United States and Europe have triggered a need for better tools for the collecting, reporting, and analysis of patient safety data. 22 The Green Movement: Rethinking Chemistry There is growing awareness that the manufacturing process is where the industry leaves its biggest mark on the environment. Now major pharmaceutical companies are working together to minimize the environmental impact of how they make their products. 30 Michael Pucci — The Man, The Mission,The Message Mike Pucci, VP of External Advocacy, at GlaxoSmithKline has taken on the role of industry advocate and is recruiting an army to help disseminate a value laden message. 38 Contents September 2008 IN EVERY ISSUE Letter from the Editor 3 UpFront A brief review of industry news at press time 6 PharmaOutlet William Clapper discusses marketing in a socially responsible world. 50 PharmaTrax Sales, marketing, and R&D trends from industry analysts 60 What’s New New healthcare related products, services, and companies 64 EMedia New electronic and Web based applications, sites, and technologies 68 On The Calendar Industry events 74 Talent Pool Executive appointments and promotions 78 Last Word GE Healthcare Financial Services’ Jason Cohen makes the case for market opportunities. 86 30 Good chemistry will lead the way to positive economic and environmental outcomes,says Skip Volante. 8 Mike Mathews says specialty marketing is about creating customer relationships. 38 GSK’s Mike Pucci is committed to raising the level of discussion around value.

Download PDF